PACB - Pacific Biosciences of California

Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to solve genetically complex problems. The company is headquartered in Menlo Park, California.

52W High

$2.72

52W Low

$0.85

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.87

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-4.15

EV/Revenue (<3 favorable)

4.91

P/S (TTM) (<3 favorable)

2.44

P/B (<3 favorable)

6.20

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

9.05%

Institutions (25–75% balanced)

56.37%

Shares Outstanding

300,371,000

Float

298,124,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

156,110,000

Gross Profit (TTM)

43,017,000

EPS (TTM)

-2.23

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

-1.13%

ROE (TTM) (>15% strong)

-1.90%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.10

Momentum

Bearish momentum

Value

-0.0311

-0.0312

Trend

Rising

Signal Cross

No cross

As of

Sep. 05, 2025